FDA Inspection 760651 — GlaxoSmithKline Consumer Healthcare, LP

GlaxoSmithKline Consumer Healthcare, LP — FEI 2210777

The FDA completed an inspection of GlaxoSmithKline Consumer Healthcare, LP on Jan 9, 2012 in Clifton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 9, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clifton, NJ (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.